TherapeuticsMD
TXMD
#10157
Rank
โ‚น1.76 B
Marketcap
โ‚น152.35
Share price
1.80%
Change (1 day)
62.62%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2025 (TTM): -โ‚น4.15

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is -โ‚น4.48. In 2021 the company made an earnings per share (EPS) of -โ‚น1,945 an increase over its 2020 EPS that were of -โ‚น3,002.

EPS history for TherapeuticsMD from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.15
2021-โ‚น1,945-35.22%
2020-โ‚น3,002-5.63%
2019-โ‚น3,18120.34%
2018-โ‚น2,64455.26%
2017-โ‚น1,703-19.15%
2016-โ‚น2,106-6%
2015-โ‚น2,24042.86%
2014-โ‚น1,56852.17%
2013-โ‚น1,031

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Agile Therapeutics
AGRX
-โ‚น346.81 7,640.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
-โ‚น2,265 50,460.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.14-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น121.15-2,803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น158.29-3,632.58%๐Ÿ‡ฌ๐Ÿ‡ง UK